Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Towards Rheumatic Heart Disease vaccine development: Defining host immune responses to Group A Streptococcal infection in Cape Town
Group A streptococcus (GAS) vaccines, as a primary prevention strategy, have the potential to prevent the spread of the bacteria, thus limiting post-sequelae diseases such as acute rheumatic fever (ARF) and rheumatic heart disease (RHD). Due to the limited supply of penicillin, adherence issues and...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Department of Medicine
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Towards Rheumatic Heart Disease vaccine development: Defining host immune responses to Group A Streptococcal infection in Cape Town
- Outcomes of asymptomatic and symptomatic rheumatic heart disease
- Invasive Group B Streptococcal disease in newborns at Groote Schuur Hospital
- Clinical characteristics and outcomes of children with rheumatic heart disease: a global rheumatic heart disease registry (REMEDY) sub-analysis
- AFROStrep (SA): a surveillance system for group A streptococcal infection in South Africa
- A study of determinants and prevalence of Rheumatic Heart Disease in Cape Town
- Computational modeling of the tissue mechanics in rheumatic heart disease patients